Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.4692
+0.0102 (2.22%)
At close: Aug 17, 2026, 4:00 PM EDT
0.4666
-0.0026 (-0.55%)
Pre-market: Aug 18, 2026, 6:40 AM EDT

Scienture Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
0.820.430.141.360.3
Revenue Growth
540.64%215.87%-89.98%354.61%-
Cost of Revenue
0.10.10.131.31-
Gross Profit
0.720.330.010.050.3
Selling, General & Admin
11.9514.6212.474.450.88
Research & Development
2.51.962.24-3.06
Operating Expenses
14.4516.5814.714.453.94
Operating Income
-13.72-16.24-14.7-4.4-3.64
Interest Expense
-3.07-4.08-1.34-1.14-0.08
Interest & Investment Income
0.490.30.140-
Other Non Operating Income (Expenses)
2.553.21-0-0.150.01
EBT Excluding Unusual Items
-13.74-16.82-15.9-5.68-3.71
Impairment of Goodwill
-21.37-21.37---
Gain (Loss) on Sale of Investments
---2.5--
Gain (Loss) on Sale of Assets
0.1-0.29-0.37-2.8-
Asset Writedown
-4.97-4.97---
Other Unusual Items
0.04-0.05---
Pretax Income
-39.95-43.51-18.78-8.48-3.71
Income Tax Expense
-1.99-1.99-0.53--
Earnings From Continuing Operations
-37.95-41.51-18.24-8.48-3.71
Earnings From Discontinued Operations
--27.31-9.36-
Net Income
-37.95-41.519.07-17.84-3.71
Net Income to Common
-37.95-41.519.07-17.84-3.71
Net Income Growth
-----
Shares Outstanding (Basic)
2915315
Shares Outstanding (Diluted)
2915315
Shares Change
236.59%354.69%341.76%-84.72%-
EPS (Basic)
-1.30-2.702.69-23.35-0.74
EPS (Diluted)
-1.30-2.702.68-23.35-0.74
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-14.44-13.38-14.28-2.23-3.35
Free Cash Flow Per Share
-0.49-0.87-4.23-2.91-0.67
Gross Margin
87.72%76.80%4.40%3.60%100.00%
Operating Margin
-1671.08%-3763.77%-10758.70%-322.36%-1213.87%
Profit Margin
-4620.92%-9618.03%6634.66%-1308.34%-1236.13%
Free Cash Flow Margin
-1758.23%-3099.95%-10448.57%-163.16%-1117.56%
EBITDA
-12.36-15.79-14.7-3.56-
EBITDA Margin
----261.20%-
D&A For EBITDA
1.360.4600.83-
EBIT
-13.72-16.24-14.7-4.4-3.64
SEC Filings: 10-K · 10-Q